Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

NCT07499128 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT07499128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07499128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
Lead sponsor
National Cancer Institute (NCI)
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 27, 2026
Completion date
August 18, 2029
Enrollment
136 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibodies bispecific, body temperature, cell and tissue-based therapy, cytokine release syndrome, cytokines, immune monitoring, immunotherapy, lymphoma, lymphoma mantle-cell, monitoring physiologic, multiple myeloma, neoplasms, precursor cell lymphoblastic leukemia-lymphoma, receptors chimeric antigen, thermometry, wearable electronic devices